| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| aldesleukin 18 megaenheter, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metylprednisolonnatriumsuccinat 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| anidulafungin 100 mg, pulver till injektionsvätska, lösning, injektionsflaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| humant immunglobulin G 2,5 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Decitabine 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| spektinomycin 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Romiplostim 500 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| humant immunglobulin G 5 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| C1-esterashämmare 500 enheter, pulver till injektionsvätska, lösning, injektionsflaska 8 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| bacitracin 50 000 enheter, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| immunglobulin mot röda hund 25 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Agalsidase beta 35 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| follitropin alfa 150 enheter, pulver till injektionsvätska, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely recombinant human antithrombin III 1750 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Somatrem 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| tiotixenhydroklorid 5 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Streptozocin 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Siltuximab 400 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Tedizolid phosphate 200 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Belinostat 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Porfimer sodium 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| hydralazinhydroklorid 20 mg, pulver till injektionsvätska, injektionsflaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Diamorphine hydrochloride 100 mg powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Botulinum toxin type A 500 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Benzylpenicillin sodium 600 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidim (som ceftazidimpentahydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidim (som ceftazidimpentahydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidim (som ceftazidimpentahydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefradine 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Colistimethate sodium 500000 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin 12 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 200 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ifosfamide 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Epirubicin hydrochloride 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Mitomycin 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Etoposide (as etoposide phosphate) 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| indometacin (som indometacinnatriumtrihydrat) 1 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dantrolene sodium 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Dolasetron mesilate 20 mg powder for solution for injection ampoule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| kanakinumab 150 mg, pulver till injektionsvätska, lösning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| temsirolimus 25 mg/ml, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 12 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| epoetin beta 10 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor VIII 500 IE + von Willebrand-faktor 1 100 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 100 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rmc) 3,33 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| tymosin alfa 1, 1,6 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| epoetin beta 100 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rmc) 1,33 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Treosulfan 5 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| epoetin beta 20 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Albiglutide 50 mg powder for solution for injection pen |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Disodium pamidronate 30 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| epoetin beta 50 000 IE, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 50 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely teicoplanin 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Vinblastine sulfate 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| epoetin beta 60 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|